News Quantified

NVCR – novocure limited - ordinary shares (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

NovoCure Limited Q1 Earnings: Core Business Accelerating [Seeking Alpha]

NovoCure Limited (NASDAQ: NVCR) had its "neutral" rating re-affirmed by analysts at Wedbush. They now have a $21.00 price target on the stock.

NovoCure Limited (NASDAQ: NVCR) had its price target lowered by analysts at HC Wainwright from $24.00 to $22.00. They now have a "neutral" rating on the stock.

Novocure Secures New $400 Million Multi-Tranche Non-Dilutive Debt Financing from Pharmakon

Novocure Reports First Quarter 2024 Financial Results

9.2%

BEAT

-3.2%

BEAT

-9.8%

BEAT

-15.7%

MISS

Form 10-Q NovoCure Ltd For: Mar 31

Form 8-K NovoCure Ltd For: May 02

Form DEFA14A NovoCure Ltd

Form DEF 14A NovoCure Ltd For: Jun 05

Form PRE 14A NovoCure Ltd For: Jun 05

Top News Gainers

1/16 Novocure Ltd (NASDAQ: NVCR) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. 11.0%

7/25 Q2/2019 6/30/2019 EPS -0.010 ZacksConsensus -0.070 ActVsEst 0.060 - Beat 8.6%

3/19 Novocure Announces Optune Lua™ as the Brand Name for the NovoTTF-100L™ System 8.2%

3/4 Novocure Ltd (NASDAQ: NVCR) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. 7.8%

4/7 Novocure Ltd (NASDAQ: NVCR) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a price target on the stock. 7.7%

5/23 FDA Approves the NovoTTF-100LTM System in Combination with Chemotherapy for the Treatment of Malignant Pleural Mesothelioma 7.3%

6/27 Novocure Ltd (NASDAQ: NVCR) was downgraded by analysts at BidaskClub from a "strong-buy" rating to a "buy" rating. 7.1%

8/14 Form 4 NovoCure Ltd For: Aug 12 Filed by: LEUNG GABRIEL 5.2%

10/31 NovoCure Limited (NVCR) CEO Asaf Danziger on Q3 2019 Results - Earnings Call Transcript [Seeking Alpha] 5.2%

1/7 Novocure Ltd (NASDAQ: NVCR) had its "buy" rating re-affirmed by analysts at Mizuho. They now have a $91.00 price target on the stock. 5.2%

Top News Decliners

4/30 Q1/2020 3/31/2020 EPS 0.040 ZacksConsensus 0.050 ActVsEst (0.010) - Miss -12.1%

3/20 German Federal Joint Committee Updates Medical Care Directive to include Tumor Treating Fields, establishing National Reimbursement for Optune in Germany -10.5%

4/7 Novocure Ltd (NASDAQ: NVCR) had its price target lowered by analysts at Wells Fargo & Co from $90.00 to $82.00. They now have an "overweight" rating on the stock. -9.6%

5/1 Novocure Ltd (NASDAQ: NVCR) had its "hold" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $78.00 price target on the stock. -8.4%

9/9 Novocure Announces 27 Presentations at the American Society for Radiation Oncology 2019 Annual Meeting -8.3%

3/10 Form 4 NovoCure Ltd For: Mar 06 Filed by: GROENHUYSEN WILHELMUS CM -8.1%

1/2 Novocure Ltd (NASDAQ: NVCR) was downgraded by analysts at Evercore ISI to an "outperform" rating. -7.9%

3/2 Form 4 NovoCure Ltd For: Feb 27 Filed by: Shah Pritesh -7.4%

10/25 Novocure Ltd (NASDAQ: NVCR) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $79.00 price target on the stock. -6.6%

1/13 Form 8-K NovoCure Ltd For: Jan 10 -5.6%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day